Journal profile · Toxicology
Cardiovascular Toxicology
ISSN 1530-7905 · eISSN 1559-0259 · Springer US · UNITED STATES · Quarterly · Founded 2001
Cardiovascular Toxicology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.27; hybrid open access; APC about USD 4,890; median 104 days to acceptance (109 articles, last 24 months); community-reported acceptance: fairly easy; 128 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cardiovascular Toxicology is published by Springer US and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chemotherapy-induced cardiotoxicity and mitigation, Cardiac electrophysiology and arrhythmias and Cardiac Ischemia and Reperfusion, together about 32% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Cardiovascular Toxicology (CaTo) is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on the mechanisms of cardiovascular toxicity and its influence on cardiovascular and metabolic diseases. In short, CaTo publishes papers that describe the effects and elucidate molecular mechanisms and signaling pathways of environmental toxins and clinically-relevant drugs on the cardiovascular system. Also covered are the detrimental effects of both established and emerging cardiovascular drugs including anti-cancer chemotherapy and gene therapy (e.g., clinical trials) as well as the side effects of non-cardiovascular targeted drugs and drugs of abuse. In addition, human and animal studies that address the cardiovascular effects of exposure to environmental toxicants (e.g., air pollution, wildfire smoke) and changing environmental conditions (e.g., heat stress) are welcomed -- especially studies that also address susceptibility factors such as sex, diet, and metabolic states. Thus, CaTo is a unique journal in which cardiovascular toxicological data across the hierarchical spectrum from in silico to clinical trials are appreciated. Studies of “Environmental Cardiology” Reports of safety and toxicity of new cardiovascular and non-cardiovascular drugs including anticancer chemotherapy Molecular pathways of environmental toxins and drugs Covers cardiovascular toxicity of drugs of abuse Cardiovascular toxicity due to interactions between toxins and susceptibility states (e.g., sex, obesity, diabetes)
From the journal's Aims & Scope
Research area (LetPub): Toxicology
Editor-in-chief Daniel J. ConklinPublisher website
Editorial board by country: 11 in mainland China (about 21%); most named United States 22, Mainland China 11, Japan 5, Germany 4, Italy 3 (52 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chemotherapy-induced cardiotoxicity and mitigationMedicine13%
- Cardiac electrophysiology and arrhythmiasMedicine10%
- Cardiac Ischemia and ReperfusionMedicine8.9%
- Air Quality and Health ImpactsEnvironmental Science6%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology4.4%
- Cardiovascular Function and Risk FactorsMedicine4.3%
- Cancer Treatment and PharmacologyMedicine3.8%
- Heavy Metal Exposure and ToxicityEnvironmental Science3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Toxicology | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
| Minor | Toxicology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
| Minor | Toxicology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.27LetPub ·
- Impact factor (publisher) 2025
- 3.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.7Publisher website ·
- CiteScore 2026-06
- 5.7LetPub ·
- SJR 2026-06
- 0.9LetPub ·
- SNIP 2026-06
- 0.79LetPub ·
- h-index
- 47LetPub ·
- h-index
- 76OpenAlex ·
- i10-index
- 785OpenAlex ·
- 2-year mean citedness
- 3.69OpenAlex ·
- Self-citation rate
- 3%LetPub ·
- Share of gold OA articles
- 22.07%LetPub ·
Volume
- Articles per year
- 126LetPub ·
- Downloads per year (publisher) 2025
- 350,900Publisher website ·
Articles by year OpenAlex count · 1,430 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 111 | 35 | 77 |
| 2025 | 128 | 32 | 431 |
| 2024 | 130 | 38 | 852 |
| 2023 | 41 | 15 | 478 |
| 2022 | 60 | 14 | 1,167 |
| 2021 | 92 | 17 | 1,600 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
104 daysMedian, submission to acceptance · P25–P75 73 days – 138 days
- Acceptance to online
- median 16 days (110 articles)
- Submission to online
- median 126 days
- Sample
- 109 articles with submission and acceptance dates (261 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 10 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,890 / EUR 3,890 / GBP 3,090 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers3, by deadline
- Advanced Cardiac Electrophysiological Models for Safety Assessment: Applications in Toxicology, Pharmacology, and Gene TherapyDeadline
- Plastics Are Everywhere, But What Do They Do To The Cardiovascular System?Deadline
- Impact of Metal Dyshomeostasis and Environmental Exposure on Cardiometabolic HealthDeadline
What to prepare6 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 10,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Graphical abstract
- Required
Article types accepted5, with length limits
- brief reportCardiovascular Toxicology publishes Research Articles, Review Articles, Protocols, and Brief Reports. Research Articles Research Articles do not have an upper w…main text ≤ 1,500 words · figures and tables ≤ 2 · references ≤ 15
- protocolCardiovascular Toxicology publishes Research Articles, Review Articles, Protocols, and Brief Reports. Research Articles Research Articles do not have an upper w…Length not stated
- research articleCardiovascular Toxicology publishes Research Articles, Review Articles, Protocols, and Brief Reports. Research Articles Research Articles do not have an upper w…Length not stated
- reviewCardiovascular Toxicology publishes Research Articles, Review Articles, Protocols, and Brief Reports. Research Articles Research Articles do not have an upper w…Length not stated
- review articleCardiovascular Toxicology publishes Research Articles, Review Articles, Protocols, and Brief Reports. Research Articles Research Articles do not have an upper w…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Cardiovascular Toxicology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 2001
- ISSN
- 1530-7905
- Electronic ISSN
- 1559-0259
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Cardiovascular Toxicology
What CAS zone is Cardiovascular Toxicology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cardiovascular Toxicology is in Zone 4 of Medicine, and in Zone 3 of the minor category Toxicology / Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cardiovascular Toxicology?
The latest impact factor listed by LetPub is 3.27; CiteScore 5.7, h-index 76.
How long does peer review take at Cardiovascular Toxicology?
Based on the dates recorded on 109 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 104 days (interquartile range 73–138 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cardiovascular Toxicology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 10,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cardiovascular Toxicology based?
Of the 52 board members whose country the journal's board page names, 11 (about 21%) are in mainland China; the countries named most often are United States (22), Mainland China (11) and Japan (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Cardiovascular Toxicology?
According to LetPub and DOAJ records, Cardiovascular Toxicology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Cardiovascular Toxicology open access, and what is the APC?
Cardiovascular Toxicology is a hybrid journal. For open-access publication: APC about USD 4,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .